EW - CIK 0001099800
Edwards Lifesciences Corp (EW) reported net income of $1.07B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $1.07B | -74.3% |
| FY 2024 | $4.17B | +197.7% |
| FY 2023 | $1.40B | -7.9% |
| FY 2022 | $1.52B | +1.3% |
| FY 2021 | $1.50B | - |
Edwards Lifesciences Corp (EW) reported net income of $1.07B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2021 and fiscal 2025, Edwards Lifesciences Corp's net income declined from $1.50B to $1.07B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.